• Registered in 1995 with the Beijing Municipal Bureau of Industry and Commerce, the company is a high-tech enterprise.
• In 1998, "Human chorionic gonadotropin diagnostic kit (colloidal gold method)" was approved by the Ministry of Health.
• In 1999, the company undertook the National 863 Program "Research on Specific Genetic Diagnostic Reagents for Pathogens" and developed the Helicobacter pylori antibody ELISA kit.
• In 2001, it was the first company in China to obtain the approval number of "Anti-Helicobacter pylori antibody ELISA kit".
• The first GMP certification was completed in 2005.
• In 2006, it was the first company in China to obtain a new drug certificate and production number for the "Human Cytomegalovirus IgM Antibody Diagnostic Kit (Enzyme-linked Immunoassay)" and won the third prize of Jiangsu Province Science and Technology Progress.
• In 2007, it was the first company in China to obtain the new drug certificate and license number for the "EB virus VCA antibody (IgA) diagnostic kit (enzyme-linked immunoassay)".
• In 2008, it was the first company in China to obtain the license number of "10 products of TORCH ELISA and 4 items of TORCH-IgM gold method".
• In 2009, it was the first company in China to obtain the license number of the "Detection Test Kit for Hepatitis D Virus".
• In 2010, it was the first company in China to obtain the license number of "Enterovirus 71 series antibody IgM / IgG detection kit (Enzyme-linked immunoassay)". And completed the second GMP certification.
• In 2011, the "Giant Cell Recombinant Antigen" project won the third prize for scientific and technological progress of Jiangsu Province.
• In 2012, it was the first company to obtain the license number of the "EB virus series test kit (Enzyme-linked Immunoassay)" for the diagnosis of infectious monocyte dysentery.
• In 2013, it was the first company to obtain the license number of the Coxsackie Group B virus IgM / IgG antibody detection kit (Enzyme-linked Immunoassay) for the detection of viral myocarditis.
• In 2014, it undertook the development of respiratory pathogen detection kits in the national twelfth five-year key research project "AIDS and Major Infectious Diseases Project". It was the first company in China to obtain the license number of 12 respiratory pathogens IgM / IgG antibody detection kits.
• In 2015, it was the first company in China to obtain the license number of the "streptococcus pneumoniae antigen detection kit" and completed the third GMP certification.
• In 2016, "EV71 virus IgM antibody detection kit" won the third prize of Beijing Science and Technology Progress. "Research and development and application of pathogenic microorganism series diagnostic reagents and technologies" won the first prize of Jiangsu Pharmaceutical Science and Technology Progress. Passed the ISO13485 certification assessment.
• In 2017, it undertook the development of diagnostic reagents for sudden acute infectious diseases in the National 13th Five-Year Key Project "Prevention and Control of Major Infectious Diseases such as AIDS and Viral Hepatitis".
• In 2018, based on 15 years of experience in the production, R & D, and marketing of ten TORCH products (Enzyme-linked Immunoassay), the company's TORCH 10 (Magneto particle Chemiluminescence Method) received license numbers.
• In 2019, it was the first domestic company to obtain the license number of respiratory pathogens (magnetic particle chemiluminescence method).
• In 2019, it obtained the license number of EB virus (magnetic particle chemiluminescence) series products.
• In 2020, it undertook the Beijing Municipal Science and Technology Commission's emergency project "R & D of New Coronavirus (2019-nCoV) Antibody Rapid Test Cassette".
